KCT0001605招募中未知
Recovery and Relapse in Early Psychosis: Biological Markers and Psychosocial Intervention
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 210
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 16(Year) 至 45(Year)（—）
- 性别
- All
入选标准
- •psychotic disorder NOS or individuals at ultra high-risk for psychosis) Brief Intermittent Psychotic Symptom Syndrome, BIPS, Genetic Risk and Deterioration Syndrome
- •- Brief Psychotic disorder, Schizophreniform disorder, Schizoaffective disorder, Schizophrenia
- •- Control of biological markers in normal volunteers
排除标准
- •- Mental retardiation, History of Head injury, Neurologic diagnosis, substance abuse, pregnant or breast-feeding patient, have a serious medical or surgical illness
研究者
相似试验
招募中
2 期
Enhancing recovery in early schizophrenia –a multi-center, two-arm, double-blind, randomized clinical trial investigating cannabidiol vs. placebo as an add-on to an individualized antipsychotic treatmentF20SchizophreniaDRKS00011151Zentralinstitut für Seelische Gesundheit180
已完成
不适用
Promoting personal recovery from psychosis: A randomised controlled trial in first episode schizophreniaSchizophrenia and other psychosesMental and Behavioural DisordersSchizophreniaISRCTN43585723HS R&D Regional Programme Register - Department of Health (UK)66
进行中（未招募）
1 期
Treating Anxiety to PrevEnt Relapse in Psychosis (TAPERS): a feasibility trialPsychosisMedDRA version: 21.1Level: PTClassification code 10001022Term: Acute psychosisSystem Organ Class: 10037175 - Psychiatric disordersEUCTR2019-001408-39-GBCardiff University40
招募中
3 期
Multimodal Prevention of First Psychotic Episode – a 2x2-Factorial Randomized Trialinvestigating the efficacy of N-Acetylcysteine (NAC) and Integrated Preventive PsychologicalIntervention (IPPI) in Subjects Clinically at High Risk for PsychosisSubjects presenting ultra-high risk (UHR) for psychosis (e.g. attenuated psychotic symptoms, brief limited intermittend psychotic symptoms or a genetic risk in combination with a decline in social functioning)DRKS00010952Zentralinstitut für seelische Gesundheit/Central Institute of Mental Health (ZI)200
进行中（未招募）
1 期
Multimodal Prevention of First Psychotic Episode – a 2x2-Factorial Randomized Trial investigating the efficacy of Acetylcysteine (ACC) and Integrated Preventive Psychological Intervention (IPPI) in Subjects Clinically at High Risk for PsychosisEUCTR2014-003076-22-DECentral Institute of Mental Health Mannheim (ZI)130